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Introduction
growth (Fig 2I-J) . 165 The dissimilarity between Daple-fl and Daple-V2 was observed in their ability to trigger 166 EMT--compared to cells expressing Daple-V2 or Daple-fl FA, those expressing Daple-fl WT 167 had significantly higher expression of Lox-L3 and Vimentin, two genes commonly associated 168 with epithelial-mesenchymal transition (EMT) (Fig 2K-L) . Furthermore, in 3-D matrigel invasion 169 assays using the transformed NIH3T3 cells exactly as done previously (Aznar et al., 2015a) . 170
Enhanced invasion, as determined by the area of invasion was detected exclusively in the6 presence of Daple-fl WT, but not in cells expressing Daple-V2 or Daple-fl FA, indicating that 172 only Daple-fl can trigger cell invasion ( Fig. 2M-N) . We found that expression of Daple-fl, but not 173
Daple-V2 is increased in the invading margins of tumors compared to the non-invasive tumor 174 cores (Fig 2O-P) , which is in keeping with our findings that Daple-V2 does not contribute to 175 EMT or higher invasiveness. These findings demonstrate that compared to Daple-fl, Daple-V2 176 serves as a more potent inhibitor of the β-Catenin-dependent canonical Wnt pathway and tumor 177 growth in colonies, but it does not enhance EMT or invasion (Fig 2Q) . suppressed cell growth and proliferation most effectively compared to either isoforms alone (Fig  188 
3B-C). 189
We previously showed that Daple-fl is downregulated earlier during cancer initiation (at 190 the stage of polyp to cancer conversion), and that its expression at high levels carries a good 191 prognosis in colorectal cancers (CRCs) (Aznar et al., 2015a) . We also showed that levels of showed that, much like Daple-fl, the expression of Daple-V2 is decreased in CRCs (Fig 3D) . 198 When we analyzed a cohort of patients with Duke's Stage II CRCs, we found that tumors that 199 express low Daple-V2 had a significantly higher incidence of oncogenic K-ras mutation (Fig 3E; 200 Table 1 ); no such correlation was seen in the case of Daple-fl. Tumors that express low Daple-fl 201 (Fig 3F) or low Daple-V2 (Fig 3G) or low levels of both isoforms (Fig 3H) have a higher 202 frequency of progression to distant metastases. Kaplan-Meier analyses revealed that Daple-V2 203 is a better prognosticator than Daple-fl (compare Fig 3I- J to 3K-L) when used standalone to 204 stratify risk for recurrence-free survival (RFS) and disease-specific survival (DSS). When 205 accounting for high vs low levels of both Daple isoforms, an additive prognostic impact was 206 seen compared to each alone (Fig 3M-N) . A correlation analysis showed that Daple-V2, but not 207 Table 2) . Together with our 210 findings on cell lines (growth curve, Wnt reporter and tumor cell colony formation assays) these 211 analyses on patient tumors suggest that while both isoforms suppress tumor cell proliferation, 212
Daple-V2 may be a more potent suppressor of tumor cell growth and proliferation than Daple-fl. 213
These findings also define the profile of dysregulated Daple-fl and Daple-V2 expression during 214 oncogenic progression in the colon: both isoforms are suppressed during colorectal cancer 215 progression, and low expression levels of both isoforms alone or simultaneously exhibit 216 decreased survival. 217
Finally, we previously discovered that high levels of expression of Daple in CTCs of 218 patients with metastatic (Duke's Stage IV) CRCs is associated with poorer prognosis compared 219 to those with low Daple in CTCs (Barbazan et al., 2016) ; high Daple is associated with higher 220 tumor recurrence at distant sites and poorer survival. Here we asked how each isoform 221 contributed to the prognostic impact using the same cohort. We found that Daple-fl, but not 222
Daple-V2, expression is increased in disseminated tumor cells compare to healthy subjects (Fig  223   3-figure supplement 1A-B) . When we assessed their prognostic impact on survival, we found 224 that although high expression of each isoform correlated with worse PFS (Fig 3-figure  225 supplement 1C, F), only Daple-fl levels carried a prognostic impact for DSS and overall survival 226 (OS) (Fig 3-figure supplement 1D-E, G-H) . These findings are in keeping with our prior 227 observations that pro-invasive and pro-EMT signatures are triggered exclusively by Daple-fl, but 228 not Daple-V2 (Fig 2M-Q) . 229
From these results we deduce that both Daple-fl and Daple-V2 cooperatively suppress 230 tumor cell proliferation, that both transcripts are reduced during adenoma-to-carcinoma 231 progression, and that the two isoforms have an additive prognostic impact, in that their reduced 232 expression in tumors carries a poor prognosis. However, the two isoforms differ in their ability to 233 trigger EMT and invasion; Daple-fl, but not Daple-V2 can support that. 234
235
Daple is downregulated during adenoma-to-carcinoma conversion; the chemopreventive 236 drug, Aspirin, has a differential effect on each isoform--237
Next we asked if suppression of Daple-fl and Daple-V2 transcripts during adenoma-to-cancer 238 progression is associated also with reduced Daple proteins. Using an antibody raised against 239 8 the C-terminus of Daple, which is identical between Daple-fl and Daple-V2, we confirmed that 240 total Daple is expressed in the normal colon and in early and intermediate adenomas, but it is 241 suppressed in advanced adenomas with villous features or high-grade dysplasia (Fig 4A-B) . In 242 cancers, ~60% expressed Daple, but ~40% did not. 243
Next we asked if levels of expression of Daple-fl and Daple-V2 change in response to 244
Aspirin, a potent chemopreventive agent that cuts the risk of CRCs by half (Thun et al., 1991 ; 245 Wunsch, 1998). We found that treatment of DLD1 cells with low-dose Aspirin reduces both 246 mRNA (Fig 4C) and protein (Fig 4D) for Daple-fl, which has both tumor-suppressive and pro-247 metastatic properties. By contrast, Aspirin increased the mRNA and protein for Daple-V2 (Fig  248   4C-D) , which has only tumor-suppressive properties. Whether these observed changes in Daple 249 isoforms are due to Aspirin's ability to inhibit cyclo-oxygenase-II (COX2), i.e., COX2-dependent 250 or independent mechanisms (Goel et al., 2003; Wunsch, 1998) 
Conclusions-262
The major discovery we report here is the identification and characterization of a novel 263 physiologic isoform of Daple, Daple-V2, which appears to contain the minimal modules that 264 As reported previously in detail, clinical data and post-operative follow-up was collected for all 518 patients; moreover, DNA was isolated for KRAS and BRAF mutation analysis, as well as 519 microsatellite instability testing (Nitsche et al., 2012) . Total mRNA was extracted by standard 520 procedures (Qiagen, Hilden, Germany), after histology guided sample selection to ensure a 521 tumor cell content of >50%, and transcribed to cDNA as described in detail earlier, for 522 expression analysis of DAPLE (Nitsche et al., 2012) . 523 524
RNA isolation, standard curve and quantitative PCR (qPCR)--525
Total RNA was isolated using an RNeasy kit (QIAGEN) as per the manufacturers' protocol. 526
First-strand cDNA was synthesized using Superscript II reverse transcriptase (Invitrogen), 527 followed by ribonuclease H treatment (Invitrogen) prior to performing quantitative real-time PCR.
528
A standard curve, to quantify mRNA copy number, was constructed using larger PCR products 529 (~700bp) that included the target sequence used in qPCR. Reactions omitting reverse 530 transcriptase were performed in each experiment as negative controls. Reactions were then run 531 on a real-time PCR system (ABI StepOnePlus; Applied Biosystems). Gene expression was 532 detected with SYBR green/Taqman assay (Invitrogen), and relative gene expression was 533 determined by normalizing to GAPDH using the comparative ΔCt/Relative standard curve 534 method. 535 536
Primer and probe sequences are as listed below. 537 538
Probes and primers used in Taqman 
Immunohistochemistry -595
Colon specimens of known histologic type were analyzed by IHC using a previously-validated 596
anti-Daple-CT rabbit polyclonal antibody raised against Daple (aa 1660-2028) (1:50; Millipore 597
Inc.). Briefly, formalin-fixed, paraffin-embedded tissue sections of 4 µm thickness were cut and 598 placed on glass slides coated with 3-aminopropyl triethoxysilane, followed by deparaffinization 599 and hydration. Heat-induced epitope retrieval was performed using citrate buffer (pH 6) in a 600 pressure cooker. Tissue sections were incubated with 3% hydrogen peroxidase for 15 min to 601 block endogenous peroxidase activity, followed by incubation with primary antibodies overnight 602 in a humidified chamber at 4°C. Immunostaining was visualized with a labeled streptavidin-biotin 603 using 3,3′-diaminobenzidine as a chromogen and counterstained with hematoxylin. All the 604 samples were first quantitatively analyzed and scored based on 2 independent criteria. First, the 605 intensity of staining was scored on a scale of 0 to 3, where 0 = no staining, 1 = light brown, 2 = 606 brown, and 3 = dark brown. Second, the percentage of the cells that stained positive in the 607 tumor area was scored on a scale of 0 to 4, where 0 = 0, 1 = ≤10%, 2 = 11-50%, 3 = 51-75%, 608
and 4 = >75%. Subsequently, each tumor sample was assigned a final score, which is the 609 product of its (intensity of staining) × (% cells that stained positive N) . In the RFS curves, cancers with low Daple-V2 alone exhibited decreased recurrence-free survival (K; significant by Log-Rank test). Although a similar trend was seen also in the case of Daple-fl (I), significance was not reached. Cancers with low levels of both isoforms exhibited decreased recurrence (M) with higher significance than each isoform alone. In the DSS curves, cancers with low Daple-fl alone or Daple-V2 alone exhibited decreased disease specific survival (J, L; significant by Log-Rank test). Cancers with low levels of both isoforms exhibited decreased survival (N) with higher significance than each isoform alone. 
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